EPIC Test Compendium Alpha
Welcome to the new Northwell Health Labs Test Directory, please call our Client Services Department at 1-800-472-5757 with any typos, corrections or issues.

Flow Cytometry - Leukemia/Lymphoma immunophenotyping

Test Catalog Information

Test Catalog Synonyms

EPIC Synonyms markers
immunophenotype
Cerner Primary MnemonicHLX Flow Cytometry Request CASE
EPIC Display NameFlow Cytometry - Leukemia/Lymphoma immunophenotyping
Allscripts (AEHR) Order Name

Flow Cytometry

Sunrise Clinical Manager (SCM) Order Name

Flow Cytometry

EPIC Inpatient Orderable Yes
EPIC Outpatient Orderable Yes
Cerner Results
Clinical Info

Phenotyping by flow cytometry can aid in the evaluation of hematopoietic neoplasms in specimens including bone marrow, whole blood, tissue, or fluid. It facilitates lineage detection (i.e. B vs T vs myeloid) and in conjunction with morphologic and other ancillary findings, can provide a confirmatory diagnosis or differential diagnoses. Phenotyping may aid in monitoring response to therapy in individuals with an established diagnosis of hematopoietic neoplasms. Markers are analyzed as needed, based on clinical evidence and history, as an initial screening panel. Additional markers are selected based on pathologist interpretation of the screening panel results to fully characterize any abnormalities identified by the screening panel. Antigens included: T/NK cell: CD2, CD3, CD4, CD5, CD7, CD8, CD16, CD56, CD57, TRCB-1, CD30, TCR gamma-delta, TCR alpha-beta, CD279, CD26 B cell: CD10, CD19, CD20, CD22, CD23, CD103, CD200, kappa, lambda, CD79b, FMC-7, CD103, cCD79a, cCD22 Myeloid/monocyte: CD11b, CD13, CD14, CD16, CD15, CD33, CD64, CD11b, CD117, myeloperoxidase, CD34 Plasma cell: CD138, CD38, cytoplasmic kappa and lamda, CD27, CD81, CD56, CD117 Miscellaneous: CD11c, CD123, CD41, CD61, CD71, TdT, CD36, CD42b, CD45, HLA-DR, TdT, CRLF-2 Poor cell viability may adversely affect antigens and compromise result accuracy and reliability.

Specimen Type

Blood, Body Fluid, CSF, Bone Marrow, Tissue

Container

Green-top (sodium heparin) tube or Lavender (EDTA) tube

Collection Instructions

Contact the Tumor Marker (Flow Cytometry) Laboratory at 516-562-4169 for collection instructions and consultation on selection of test(s). Test for PNH is performed at Long island Jewish Flow Lab 718-470-3035 and requires two Lavender (EDTA) tubes - Done on Peripheral Blood Samples Only. Immediate Delivery to the Lab is recommended. Submit only 1 of the following specimens: Blood - Green-top (sodium heparin) tube or Lavender top (EDTA) tube. Recommended Amount: 3 mL whole blood (1 mL min) Transport Temperature: Room Temperature Collection Instructions: Deliver specimen to laboratory within 12 Hours Note: 1. Indicate blood on request form . 2. Comment Rituximab Sensitivity on form Bone Marrow - Obtain 3 mL of bone marrow in a green-top (sodium heparin) tube or lavender top (EDTA) tube. Forward promptly at ambient temperature. Deliver specimen to laboratory within 12 Hours Note: 1. Indicate bone marrow on request form. 2. Label with Rituximab Sensitivity. Bone Marrow aspirate smears (recommend 4-6) must accompany all bone marrow specimens. Include Peripheral Blood Smear whenever possible.  CAUTION: If sending unstained slides as part of biopsy kit, please package slides separately outside of the biopsy box. Do not freeze.    CSF -  3mL desired in sterile container at Room Temperature. Do not freeze. Deliver to lab immediately is recommended. If needed, Refrigerate to maintain 2-8°C. Tissue - Obtain tissue in sterile Container and indicate the source - 0.5cm3 recommended. Recommended Storage medium - RPMI 1640 but Saline can be substituted. Transfer at Room Temperature. Do not freeze.  Deliver to the lab immediately. If needed, Refrigerate to maintain 2-8°C. Body Fluid - Obtain 3-5mL Body Fluid in sterile container. Indicate Fluid type on the sample. Transfer at Room Temperature. Deliver to lab immediately is recommended. If needed, Refrigerate to maintain 2-8°C.

Transport Instructions

RoomTemperature

Specimen Stability

Immediate delivery to the lab is recommended

Methodology

Flow Cytometry at minimum includes for a B-cell work-up - CD5, CD10, CD19, CD20, CD23, CD38, CD200 kappa Light chain, Lambda Light chain and CD45. For a T-cell  CD57, CD56, CD7, CD8, CD2, CD4, CD3, CD5, CD16 and CD45. For at minimum Leukemia work-up CD13, CD33, CD34, CD117 and CD45.  For a Plasma Cell work-up, at minimum - CD38, CD138,  cytoplasmic Kappa, cytoplasmic Lambda and CD45. Additional markers may be performed based on diagnosis and cell count.

Days Performed

Laboratory is open Mondays through Fridays 7:00AM to 12:00AM. All testing is available during these hours. Limited testing is available on Saturdays from 8AM-4PM. Laboratory is closed on Sundays and Legal Holidays – New Year’s, Martin Luther King Jr, President’s, Memorial, Independence, Labor, Thanksgiving and Christmas Day.

Performing Laboratory

Northwell Health Laboratories

CPT

86356

PDM

5299996

Desired Epic Build Flow Cytometry - Leukemia/Lymphoma immunophenotyping

Cerner Primary Mnemonic: HLX Flow Cytometry Request CASE
PDM 5299996
Informatics - WorkgroupFlow Cytometry
Synonyms *markers
immunophenotype
Display Name *Flow Cytometry - Leukemia/Lymphoma immunophenotyping
Order Entry Specimen Sources *
Order Entry Specimen Types
Apheresis Product
Blood
Bone Marrow
CSF
Other
TSSUE
Tissue
Specimen Navigator Specimen Types
Specimen Navigator Specimen Sources
Specimen Navigator Short Name
Ordering info (EPIC SmartText)Phenotyping by flow cytometry can aid in the evaluation of hematopoietic neoplasms in specimens including bone marrow, whole blood, tissue, or fluid. It facilitates lineage detection (i.e. B vs T vs myeloid) and in conjunction with morphologic and other ancillary findings, can provide a confirmatory diagnosis or differential diagnoses. Phenotyping may aid in monitoring response to therapy in individuals with an established diagnosis of hematopoietic neoplasms. Markers are analyzed as needed, based on clinical evidence and history, as an initial screening panel. Additional markers are selected based on pathologist interpretation of the screening panel results to fully characterize any abnormalities identified by the screening panel. Antigens included: T/NK cell: CD2, CD3, CD4, CD5, CD7, CD8, CD16, CD56, CD57, TRCB-1, CD30, TCR gamma-delta, TCR alpha-beta, CD279, CD26 B cell: CD10, CD19, CD20, CD22, CD23, CD103, CD200, kappa, lambda, CD79b, FMC-7, CD103, cCD79a, cCD22 Myeloid/monocyte: CD11b, CD13, CD14, CD16, CD15, CD33, CD64, CD11b, CD117, myeloperoxidase, CD34 Plasma cell: CD138, CD38, cytoplasmic kappa and lamda, CD27, CD81, CD56, CD117 Miscellaneous: CD11c, CD123, CD41, CD61, CD71, TdT, CD36, CD42b, CD45, HLA-DR, TdT, CRLF-2 Poor cell viability may adversely affect antigens and compromise result accuracy and reliability.
IP Orderable Yes
OP Orderable Yes
AOEs *

AP AOEs
Special History No
Build Comments
Filter *pathology
Procedure Category Change
Cerner Results

Actual Epic build

Procedure Id 72348
Pdm 5299996
Order Display Name Flow Cytometry - Leukemia/Lymphoma immunophenotyping
Procedure Name FLOW CYTOMETRY
Procedure Master Number LAB1729
Short Procedure Name Flow Cytometry
Category Code 15.0
Category Code Record Name LAB CYTOGENETICS ORDERABLES
Synonyms MARKERS IMMUNOPHENOTYPE
Clinically Active Yes
Orderable Yes
Performable Yes
Filter Genomics Not a Genomics Procedure
Reference Link Url
Ordering Instructions
Default Specimen Type
Specimen Type Pick List Cerebrospinal Fluid Tissue Blood Bone Marrow Other Apheresis Product
Specimen Type List
Op Specimen Type List
Specimen Source Pick List Cerebrospinal Fluid Bone Marrow Other
Specimen Source Default - Male
Specimen Source Default - Female
Specimen Source List Cerebrospinal Fluid Bone Marrow Other
Op Specimen Source List
Ip Lab Test Components For Report
Op Lab Test Components For Report
Order Questions ["3045300170", "3045300171", "3045300173"]
Order Questions Record Name NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY
Inpatient Order Questions []
Inpatient Order Questions Record Name
Order Specific Question Override Yes
Inpatient Question Override Yes
Location Restrict List Ip
Location Restrict List Ip Record Name
Location Restrict List Include Ip
Location Restrict List Op
Location Restrict List Op Record Name
Location Restrict List Includes Op
Edp Amb Order Specific Questions Record Name NH IP PATIENT COMPLETED CONSENT
Edp Ip Order Specific Questions Record Name NH IP PATIENT COMPLETED CONSENT
Edp Ip Specimen Source
Edp Op Specimen Source
Edp Ip Specimen Type
Edp Op Specimen Type
Derived Edp Ip Buttons S
Derived Edp Ip Buttons T
Derived Edp Op Buttons S
Derived Edp Op Buttons T
Ip Orderable 1
Op Orderable 1
EPIC OP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3045300170 NH IP HOME COLLECT DATE Start Date Date Yes
3045300171 NH IP HOME COLLECT DAYS Days Custom List Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
Yes
3045300173 NH IP HOME COLLECT MEDICALLY NECESSARY Medically Necessary? Yes/No Yes
EPIC IP AOEs

EPIC Components (results)